Zhongyong Wang

1055 Sanxiang Road
Suzhou, 215004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Machine learning-based mri radiomics for predicting bevacizumab response in peritumoral brain edema of glioblastoma.

Machine learning-based mri radiomics for predicting bevacizumab response in peritumoral brain edema of glioblastoma.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: April 08, 2026

TIGAR Maintains Mitotic Spindle Organization and βII-Tubulin Stability in Glioma Stem Cells.

TIGAR Maintains Mitotic Spindle Organization and βII-Tubulin Stability in Glioma Stem Cells.

Journal: CNS neuroscience & therapeutics

Published: March 22, 2026

Ruthenium-gallic acid nanozymes encapsulated in 3D bioprintable photosensitive hydrogels for synergistic PTT/CDT therapy of glioblastoma.

Ruthenium-gallic acid nanozymes encapsulated in 3D bioprintable photosensitive hydrogels for synergistic PTT/CDT therapy of glioblastoma.

Journal: Journal of nanobiotechnology

Published: February 11, 2026

Bioprintable and injectable TiO-loaded hydrogels for photothermal therapy of glioma.

Bioprintable and injectable TiO-loaded hydrogels for photothermal therapy of glioma.

Journal: Materials today. Bio

Published: February 17, 2025

FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.

FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 01, 2023

Molecular genetic features and clinical manifestations in Chinese familial cerebral cavernous malformation: from a novel KRIT1/CCM1 mutation (c.1119dupT) to an overall view.

Molecular genetic features and clinical manifestations in Chinese familial cerebral cavernous malformation: from a novel KRIT1/CCM1 mutation (c.1119dupT) to an overall view.

Journal: Frontiers in neuroscience

Published: March 11, 2023

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution.

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution.

Journal: Frontiers in oncology

Published: September 19, 2022

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma.

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma.

Journal: Frontiers in oncology

Published: June 14, 2022

Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.

Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.

Journal: Translational cancer research

Published: March 31, 2022

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration.

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration.

Journal: Annals of translational medicine

Published: December 15, 2021

PSMD12 promotes glioma progression by upregulating the expression of Nrf2.

PSMD12 promotes glioma progression by upregulating the expression of Nrf2.

Journal: Annals of translational medicine

Published: May 14, 2021

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.

Journal: Cancer medicine

Published: January 28, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026